Stem cell and gene-based approaches for cardiac repair

Ibrahim Elmadbouh, Muhammad Ashraf

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Besides current medical and surgical revascularization therapy, novel therapeutic interventions such as administration of recombinant or purified proteins, and cell and gene therapies have been used to compensate for the loss of cardiomyocytes and to limit the process of left ventricular remodeling. These approaches have been evaluated for use both alone and as adjuncts to bypass grafting in patients who are not candidates for coronary artery surgery. Additional studies need to focus on the development of strategies for optimization of cell delivery, which include adequate cell volume, preconditioned or gene modified to optimal functional results. Induced pluripotent cells from adult somatic cells, ex vivo cell-based gene therapy, and endogenous progenitor stem cell mobilization by mobilizing drugs (alone or/and as an adjuvant with stem cell therapy) into ischemic tissues may represent new directions for cardiac repair. Recently, stem cell exosome-based therapy in clinical settings may represent a novel and viable cardio-regenerative strategy.

Original languageEnglish (US)
Title of host publicationDesign of Nanostructures for Versatile Therapeutic Applications
PublisherElsevier
Pages31-96
Number of pages66
ISBN (Electronic)9780128136683
ISBN (Print)9780128136676
DOIs
StatePublished - Jan 27 2018
Externally publishedYes

Fingerprint

Stem cells
Gene therapy
Repair
Stem Cells
Genes
Cell- and Tissue-Based Therapy
Genetic Therapy
Hematopoietic Stem Cell Mobilization
Exosomes
Surgery
Ventricular Remodeling
Cell Size
Cardiac Myocytes
Tissue
Proteins
Coronary Vessels
Therapeutics
Pharmaceutical Preparations

Keywords

  • Exosomes
  • Gene therapy
  • Mobilizing and homing drugs
  • Myocardial repair
  • Myocardium remodeling
  • Reprogramming cells
  • Stem cell

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Engineering(all)

Cite this

Elmadbouh, I., & Ashraf, M. (2018). Stem cell and gene-based approaches for cardiac repair. In Design of Nanostructures for Versatile Therapeutic Applications (pp. 31-96). Elsevier. https://doi.org/10.1016/B978-0-12-813667-6.00002-4

Stem cell and gene-based approaches for cardiac repair. / Elmadbouh, Ibrahim; Ashraf, Muhammad.

Design of Nanostructures for Versatile Therapeutic Applications. Elsevier, 2018. p. 31-96.

Research output: Chapter in Book/Report/Conference proceedingChapter

Elmadbouh, I & Ashraf, M 2018, Stem cell and gene-based approaches for cardiac repair. in Design of Nanostructures for Versatile Therapeutic Applications. Elsevier, pp. 31-96. https://doi.org/10.1016/B978-0-12-813667-6.00002-4
Elmadbouh I, Ashraf M. Stem cell and gene-based approaches for cardiac repair. In Design of Nanostructures for Versatile Therapeutic Applications. Elsevier. 2018. p. 31-96 https://doi.org/10.1016/B978-0-12-813667-6.00002-4
Elmadbouh, Ibrahim ; Ashraf, Muhammad. / Stem cell and gene-based approaches for cardiac repair. Design of Nanostructures for Versatile Therapeutic Applications. Elsevier, 2018. pp. 31-96
@inbook{c5513ab512094f728f355747efe0ea03,
title = "Stem cell and gene-based approaches for cardiac repair",
abstract = "Besides current medical and surgical revascularization therapy, novel therapeutic interventions such as administration of recombinant or purified proteins, and cell and gene therapies have been used to compensate for the loss of cardiomyocytes and to limit the process of left ventricular remodeling. These approaches have been evaluated for use both alone and as adjuncts to bypass grafting in patients who are not candidates for coronary artery surgery. Additional studies need to focus on the development of strategies for optimization of cell delivery, which include adequate cell volume, preconditioned or gene modified to optimal functional results. Induced pluripotent cells from adult somatic cells, ex vivo cell-based gene therapy, and endogenous progenitor stem cell mobilization by mobilizing drugs (alone or/and as an adjuvant with stem cell therapy) into ischemic tissues may represent new directions for cardiac repair. Recently, stem cell exosome-based therapy in clinical settings may represent a novel and viable cardio-regenerative strategy.",
keywords = "Exosomes, Gene therapy, Mobilizing and homing drugs, Myocardial repair, Myocardium remodeling, Reprogramming cells, Stem cell",
author = "Ibrahim Elmadbouh and Muhammad Ashraf",
year = "2018",
month = "1",
day = "27",
doi = "10.1016/B978-0-12-813667-6.00002-4",
language = "English (US)",
isbn = "9780128136676",
pages = "31--96",
booktitle = "Design of Nanostructures for Versatile Therapeutic Applications",
publisher = "Elsevier",
address = "Netherlands",

}

TY - CHAP

T1 - Stem cell and gene-based approaches for cardiac repair

AU - Elmadbouh, Ibrahim

AU - Ashraf, Muhammad

PY - 2018/1/27

Y1 - 2018/1/27

N2 - Besides current medical and surgical revascularization therapy, novel therapeutic interventions such as administration of recombinant or purified proteins, and cell and gene therapies have been used to compensate for the loss of cardiomyocytes and to limit the process of left ventricular remodeling. These approaches have been evaluated for use both alone and as adjuncts to bypass grafting in patients who are not candidates for coronary artery surgery. Additional studies need to focus on the development of strategies for optimization of cell delivery, which include adequate cell volume, preconditioned or gene modified to optimal functional results. Induced pluripotent cells from adult somatic cells, ex vivo cell-based gene therapy, and endogenous progenitor stem cell mobilization by mobilizing drugs (alone or/and as an adjuvant with stem cell therapy) into ischemic tissues may represent new directions for cardiac repair. Recently, stem cell exosome-based therapy in clinical settings may represent a novel and viable cardio-regenerative strategy.

AB - Besides current medical and surgical revascularization therapy, novel therapeutic interventions such as administration of recombinant or purified proteins, and cell and gene therapies have been used to compensate for the loss of cardiomyocytes and to limit the process of left ventricular remodeling. These approaches have been evaluated for use both alone and as adjuncts to bypass grafting in patients who are not candidates for coronary artery surgery. Additional studies need to focus on the development of strategies for optimization of cell delivery, which include adequate cell volume, preconditioned or gene modified to optimal functional results. Induced pluripotent cells from adult somatic cells, ex vivo cell-based gene therapy, and endogenous progenitor stem cell mobilization by mobilizing drugs (alone or/and as an adjuvant with stem cell therapy) into ischemic tissues may represent new directions for cardiac repair. Recently, stem cell exosome-based therapy in clinical settings may represent a novel and viable cardio-regenerative strategy.

KW - Exosomes

KW - Gene therapy

KW - Mobilizing and homing drugs

KW - Myocardial repair

KW - Myocardium remodeling

KW - Reprogramming cells

KW - Stem cell

UR - http://www.scopus.com/inward/record.url?scp=85054420048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054420048&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-813667-6.00002-4

DO - 10.1016/B978-0-12-813667-6.00002-4

M3 - Chapter

SN - 9780128136676

SP - 31

EP - 96

BT - Design of Nanostructures for Versatile Therapeutic Applications

PB - Elsevier

ER -